𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interference of proteins involved in the cytoplasmic sequestration of p53 with human papillomavirus E6–mediated degradation

✍ Scribed by Jennifer S. Isaacs; J. Carl Barrett; Bernard E. Weissman


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
141 KB
Volume
24
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

✦ Synopsis


The oncogenic human papillomaviruses (HPVs) are able to efficiently target p53 for degradation by the ubiquitin pathway. We previously demonstrated inefficient HPV E6-mediated degradation and resulting high steady-state levels of p53 in cell hybrids between a peripheral neuroepithelioma cell line and a cervical carcinoma cell line (HeLa). We now show that the p53 protein in these cell hybrids was cytoplasmically sequestered and exhibited sporadic punctate staining, which is characteristic of the p53 expression pattern observed in neuroblastic neuroblastoma (NB) cell lines, in which p53 is also sequestered. We hypothesized that the cytoplasmic sequestration of p53 in the cell hybrids might correlate with its inability to be rapidly degraded by HPV E6. Using NB cell lines as a model system to test this hypothesis, we demonstrated that the introduction of HPV E6 into two NB cell lines resulted in p53 insensitivity to HPV E6-mediated degradation. This was assessed by both pulse-chase analysis of p53 in metabolically labeled NB cells and western blotting. The enhanced stability of p53 was not due to a lack of HPV E6 expression or to a mutant conformation of the p53 protein. Our results therefore suggest that proteins involved in the cytoplasmic sequestration of p53 may also interfere with the ability of HPV E6 to target p53 for degradation.


📜 SIMILAR VOLUMES


Targetting of the N-terminal domain of t
✍ Christine Giovane; Gilles Travé; Amélie Briones; Yves Lutz; Bohdan Wasylyk; Etie 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

The E6 protein of cancer-associated human papillomavirus type 16 (HPV16) binds to cellular p53 and promotes its degradation through the ubiquitin pathway. In an attempt to identify the regions of E6 that could be targetted for functional inhibition, we generated monoclonal antibodies to the HPV16 E6